Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis

E Masini1, L Mugnai, M Foschi

  • 1Department of Preclinical and Clinical Pharmacology, University of Flourence, Italy.

Insights

Liver cirrhosis patients show altered inflammatory cell function. Polymorphonuclear leukocytes (PMNs) produce less superoxide but more nitric oxide (NO), indicating a shift in immune response related to liver disease.

Area of Science:

  • Immunology
  • Hepatology
  • Cellular Biology

Background:

  • Liver cirrhosis is associated with systemic inflammation and altered immune cell function.
  • Polymorphonuclear leukocytes (PMNs) and monocytes play critical roles in innate immunity and inflammation.
  • Understanding immune cell responses in cirrhosis is crucial for managing complications.

Purpose of the Study:

  • To evaluate superoxide (O2-) and nitric oxide (NO) production by PMNs and monocytes in patients with liver cirrhosis.
  • To investigate the activity of NO synthase in leukocytes from cirrhotic patients.
  • To explore correlations between inflammatory cell changes and hemodynamic parameters like cardiac index.

Main Methods:

  • Isolation of PMNs and monocytes from cirrhotic patients and healthy controls.
  • Stimulation of leukocytes with opsonized zymosan to assess O2- production.
  • Measurement of NO production through inhibition of platelet aggregation and cGMP content analysis.
  • Assay of NO synthase activity in leukocyte extracts.
  • Correlation analysis between cellular function and cardiac index.

Main Results:

  • PMNs from cirrhotic patients exhibited reduced O2- production compared to controls.
  • Leukocytes from cirrhotic patients demonstrated enhanced NO production, evidenced by platelet aggregation inhibition and increased cGMP.
  • Higher NO synthase activity was observed in leukocytes of cirrhotic patients.
  • A significant correlation was found between the cardiac index and alterations in inflammatory cell function.

Conclusions:

  • Immune cell dysfunction, specifically reduced O2- and increased NO production by PMNs, is characteristic of liver cirrhosis.
  • Elevated NO synthase activity contributes to the altered inflammatory profile in cirrhotic patients.
  • These immune cell changes may be linked to hemodynamic alterations, suggesting a complex interplay in the pathophysiology of liver cirrhosis.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...